When a veterinarian suspects your dog has an endocrine disorder, such as Cushing's disease, the diagnostic journey often begins with a series of blood tests designed to assess hormonal balance. Among these, the low dose dexamethasone suppression test, or LDDS, stands as a critical tool for confirming pathological cortisol production. This specific procedure helps to differentiate between naturally elevated cortisol and a true, pathological overproduction that requires medical intervention.
Understanding the Physiology Behind the Test
The test operates on the fundamental principle of negative feedback within the hypothalamic-pituitary-adrenal axis, or HPA axis. In a healthy dog, the administration of a synthetic corticosteroid, dexamethasone, should signal the body to halt its own production of cortisol. The pituitary gland receives this signal and reduces the stimulation of the adrenal glands, leading to a measurable drop in circulating cortisol levels. When this feedback loop is broken, as is the case with adrenal tumors or pituitary-dependent hyperadrenocorticism, the cortisol levels remain stubbornly high, revealing the presence of disease.
The Clinical Indications for Testing
Veterinarians do not order this test lightly; it is a targeted response to specific clinical signs that suggest hormonal imbalance. Owners might notice a constellation of symptoms that prompt the visit, including a pot-bellied appearance, excessive panting, lethargy, and muscle wasting. Perhaps the most visually distinct sign is the thinning of the skin, which becomes fragile and prone to bruising or poor hair regrowth. The LDDS is particularly valuable when the initial screening test, the ACTH stimulation test, yields ambiguous results, providing a more nuanced view of the dog's hormonal regulation.
Step-by-Step Procedure and Protocol
The administration of the test is standardized to ensure accuracy, requiring strict adherence to protocol by the veterinary team. The process typically involves three blood draws from the patient. The first blood sample, known as the baseline, is taken immediately before the medication is administered. A precise, low dose of dexamethasone is then injected intravenously or intramuscularly. Subsequent blood samples are collected at the specific intervals of four hours and eight hours post-injection. This timeline is crucial, as it allows the medical team to track the trajectory of the cortisol levels in response to the external steroid.
Pre-Test Requirements
All food and treats must be withheld for a minimum of 8 hours prior to the procedure to prevent interference with glucose levels.
Water should generally be available unless specifically restricted by the veterinarian.
It is essential to inform the clinic of any medications or supplements the dog is taking, as drugs like phenobarbital or ketoconazole can alter the results.
Maintaining a calm environment before the test helps prevent stress-induced cortisol spikes that could complicate interpretation.
Interpreting the Results
Understanding the outcome of the LDDS requires a keen eye on the numerical data presented in the results table. The interpretation hinges on the cortisol level measured at the four-hour mark. A suppressed level, typically defined as a cortisol concentration less than 1.4 µg/dL, indicates a healthy, responsive adrenal system. Conversely, a lack of suppression, where the cortisol remains above the cutoff value, strongly suggests pathological hyperadrenocorticism. The eight-hour sample is sometimes used as a secondary confirmation, but the four-hour value is the primary diagnostic criterion.
